Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

LogicBio Therapeutics (LOGC) Insider Trading & Ownership

LogicBio Therapeutics logo

LogicBio Therapeutics (NASDAQ:LOGC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$24,641.16
Get LOGC Insider Trade Alerts

Want to know when executives and insiders are buying or selling LogicBio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LOGC Insider Buying and Selling by Quarter

LogicBio Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2024Brett JustCFOSell4,369$5.64$24,641.16  
(Data available from 1/1/2013 forward)

LOGC Insider Trading Activity - Frequently Asked Questions

The list of insiders at LogicBio Therapeutics includes Brett Just. Learn more on insiders at LOGC.

8.10% of LogicBio Therapeutics stock is owned by insiders. Learn more on LOGC's insider holdings.

The following insider sold LOGC shares in the last 24 months: Brett Just ($24,641.16).

Insiders have sold a total of 4,369 LogicBio Therapeutics shares in the last 24 months for a total of $24,641.16 sold.



This page (NASDAQ:LOGC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners